Search

Your search keyword '"SPADARO, Giuseppe"' showing total 901 results

Search Constraints

Start Over You searched for: Author "SPADARO, Giuseppe" Remove constraint Author: "SPADARO, Giuseppe"
901 results on '"SPADARO, Giuseppe"'

Search Results

2. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study

4. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

7. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

10. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

12. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)

15. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

17. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

18. Severe asthma: One disease and multiple definitions

19. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best

21. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

22. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

23. High Prevalence of Long COVID in Common Variable Immunodeficiency:An Italian Multicentric Study

24. Roles of Immune Cells in Hereditary Angioedema

25. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.

27. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

28. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality

29. Lanadelumab Effectiveness and Safety in Adolescent Patients With Hereditary Angioedema Aged 12 to <18 Years: Pooled Results From the Real-World ENABLE and EMPOWER Studies

30. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

32. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder

36. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies

37. The Severe Asthma Network in Italy: Findings and Perspectives

38. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

39. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.

41. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review

42. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022

45. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

49. Real-world effectiveness and characteristics of Super-Responders to Mepolizumab and Benralizumab in severe eosinophilic asthma and EGPA

Catalog

Books, media, physical & digital resources